Sensitivity, specificity, inclusivity and exclusivity of the updated Aptima Combo 2 assay, which provides detection coverage of the new diagnostic-escape Chlamydia trachomatis variants

BACKGROUND: Four new variants of Chlamydia trachomatis (nvCTs), detected in several countries, cause false-negative or equivocal results using the Aptima Combo 2 assay (AC2; Hologic). We evaluated the clinical sensitivity and specificity, as well as the analytical inclusivity and exclusivity of the...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMC Infect Dis
Glavni autori: Unemo, Magnus, Hansen, Marit, Hadad, Ronza, Puolakkainen, Mirja, Westh, Henrik, Rantakokko-Jalava, Kaisu, Thilesen, Carina, Cole, Michelle J., Boiko, Iryna, Lan, Pham T., Golparian, Daniel, Ito, Shin, Sundqvist, Martin
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2020
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7298785/
https://ncbi.nlm.nih.gov/pubmed/32546213
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-020-05148-7
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items